2018
DOI: 10.1016/j.envint.2018.01.011
|View full text |Cite
|
Sign up to set email alerts
|

Comparing the toxic potency in vivo of long-chain perfluoroalkyl acids and fluorinated alternatives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
151
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 276 publications
(157 citation statements)
references
References 54 publications
4
151
1
Order By: Relevance
“…The long-chain perfluoroalkyl carboxylates (PFCAs) and perfluoroalkane sulfonates (PFSAs) are of particular concern due to persistent, toxic, and bioaccumulative properties (Gomis et al, 2018;Shi et al, 2018). In homologous series of PFCAs and PFSAs, the logarithm of the bioaccumulation factor (Log BAF) and the number of perfluoroalkyl carbon atoms were shown to be linearly correlated over a certain chain length range (Hong et al, 2015;Kwadijk et al, 2010;Xu et al, 2014).…”
Section: Introductionmentioning
confidence: 99%
“…The long-chain perfluoroalkyl carboxylates (PFCAs) and perfluoroalkane sulfonates (PFSAs) are of particular concern due to persistent, toxic, and bioaccumulative properties (Gomis et al, 2018;Shi et al, 2018). In homologous series of PFCAs and PFSAs, the logarithm of the bioaccumulation factor (Log BAF) and the number of perfluoroalkyl carbon atoms were shown to be linearly correlated over a certain chain length range (Hong et al, 2015;Kwadijk et al, 2010;Xu et al, 2014).…”
Section: Introductionmentioning
confidence: 99%
“…A recently published carcinogenicity study of PFOA in rats [41] found increased incidence of pancreatic tumors in males at all doses tested (approximately 1.1 to 4.6 mg/kg/day) which were lower and administered at an earlier age than in previous studies, highlighting the importance of developmental exposure with regards to carcinogenic classification and potential. Additionally, for other toxicological endpoints, short-chain PFAS with faster elimination rates were found to be equally or more toxic than PFOA when accounting for difference in toxicokinetics [46], a finding that may be relevant for cancer risk assessment.…”
Section: Existing Research On Pfas Exposure and Cancer Riskmentioning
confidence: 95%
“…For example, data submitted by Pérez and coworkers showed that PFHxA concentration in liver was about 8 times higher than that measured for PFOA, and PFBA concentration in lung tissue was about 10 times higher than that measured for PFOA and PFOS. Moreover, adverse health effects (e.g., impact to hormone system, toxicokinetic activity) occurring as a result of exposure to PFOA and PFOS are similar to those caused by exposure to the longchain compounds [211,212]. Although short-chain PFAAs are considered to have properties of very high concern, these compounds are increasingly used [213].…”
Section: Regulatory Actions Regarding Pfaasmentioning
confidence: 99%